First Time Loading...

EBOS Group Ltd
NZX:EBO

Watchlist Manager
EBOS Group Ltd Logo
EBOS Group Ltd
NZX:EBO
Watchlist
Price: 34.3 NZD -3.24% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one EBO stock under the Base Case scenario is 77.08 NZD. Compared to the current market price of 34.3 NZD, EBOS Group Ltd is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EBO Relative Value
Base Case
77.08 NZD
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
66
vs Industry
80
Median 3Y
0.6
Median 5Y
0.5
Industry
2.4
Forward
0.5
More Details
23.3
P/E
P/E
Price to Earnings
23.3
vs History
76
vs Industry
24
Median 3Y
30
Median 5Y
25.4
Industry
23.2
Forward
19.4
More Details
17.8
P/OCF
P/OCF
Price to OCF
17.8
vs History
68
vs Industry
24
Median 3Y
19.7
Median 5Y
21.4
Industry
15.5
More Details
9.8
P/FCFE
P/FCFE
Price to FCFE
9.8
vs History
60
vs Industry
34
Median 3Y
7.6
Median 5Y
12
Industry
23.5
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
88
vs Industry
35
Median 3Y
3.1
Median 5Y
2.9
Industry
2.2
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
52
vs Industry
77
Median 3Y
0.6
Median 5Y
0.6
Industry
2.5
Forward
0.5
More Details
4.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.6
vs History
66
vs Industry
47
Median 3Y
5.9
Median 5Y
4.8
Industry
5.2
More Details
15.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.6
vs History
77
vs Industry
23
Median 3Y
20.5
Median 5Y
16.7
Industry
12.5
Forward
11.5
More Details
15.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
15.6
vs History
77
vs Industry
29
Median 3Y
20.5
Median 5Y
16.7
Industry
17.2
Forward
13.9
More Details
21.5
EV/OCF
EV/OCF
Enterprise Value to OCF
21.5
vs History
58
vs Industry
21
Median 3Y
21.7
Median 5Y
22.7
Industry
15.1
More Details
35
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35
vs History
46
vs Industry
15
Median 3Y
35.2
Median 5Y
34.9
Industry
19.7
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
93
vs Industry
42
Median 3Y
2.1
Median 5Y
2
Industry
2
More Details

Multiples Across Competitors

EBO Competitors Multiples
EBOS Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
EBOS Group Ltd
NZX:EBO
6.6B NZD 0.5 23.3 15.6 15.6
US
Mckesson Corp
NYSE:MCK
71.2B USD 0.2 23.7 16.5 19.1
US
Cencora Inc
NYSE:COR
48B USD 0.2 25.7 13.2 18.5
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
25.2B USD 0.1 39.4 8.8 11.9
US
Henry Schein Inc
NASDAQ:HSIC
9.5B USD 0.8 22.7 11.9 16
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
62.6B HKD 0.1 6.5 1.5 1.8
CN
Huadong Medicine Co Ltd
SZSE:000963
57.5B CNY 1.4 21.3 15.5 15.5
IT
Amplifon SpA
MIL:AMP
7.1B EUR 3.1 45.9 14.8 29.2
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
50.8B CNY 0.2 13.5 8 8

See Also

Summary
EBO intrinsic value, competitors valuation, and company profile.
DCF Valuation
EBO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EBO stock valuation using valuation multiples.
Wall Street Estimates
EBO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EBO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.